Novartis AG (NVSEF)

Novartis AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13,609	13,393	7,517	12,407	9,658	11,112
Short-Term Investments	242	680	11,209	15,817	1,746	232
Cash & Short-Term Investments	13,851	14,073	18,726	28,224	11,404	11,344
Cash Growth	8.08%	-24.85%	-33.65%	147.49%	0.53%	-28.36%
Accounts Receivable	7,966	7,107	8,066	8,005	8,217	8,301
Other Receivables	184	2,140	1,735	1,558	1,746	1,928
Receivables	8,150	9,247	9,801	9,563	9,963	10,229
Inventory	5,939	5,913	7,175	6,666	7,131	5,982
Prepaid Expenses	-	764	911	1,102	943	898
Other Current Assets	3,324	484	297	163	232	1,051
Total Current Assets	31,264	30,481	36,910	45,718	29,673	29,504
Property, Plant & Equipment	11,201	10,924	12,195	13,106	13,939	13,746
Long-Term Investments	1,545	1,827	1,606	2,268	11,611	10,434
Goodwill	24,930	23,341	29,301	29,595	29,999	26,524
Other Intangible Assets	27,902	21,550	27,223	28,683	32,109	23,363
Long-Term Accounts Receivable	-	104	59	70	83	66
Long-Term Deferred Tax Assets	4,646	4,309	3,739	3,743	3,933	7,909
Long-Term Deferred Charges	-	5,329	4,421	5,499	4,700	5,424
Other Long-Term Assets	2,036	1,966	1,914	3,035	1,642	1,241
Total Assets	103,524	99,945	117,453	131,795	127,778	118,370
Accounts Payable	4,087	4,926	5,146	5,553	5,403	5,424
Accrued Expenses	-	5,174	5,387	5,149	5,503	5,180
Short-Term Debt	-	3,893	3,635	3,606	7,319	4,844
Current Portion of Long-Term Debt	6,566	2,282	2,296	2,689	2,466	2,187
Current Portion of Leases	247	230	251	275	286	246
Current Income Taxes Payable	2,165	1,893	2,533	2,415	2,458	2,194
Current Unearned Revenue	-	98	123	123	56	114
Other Current Liabilities	15,067	7,894	9,285	10,398	9,568	8,075
Total Current Liabilities	28,132	26,390	28,656	30,208	33,059	28,264
Long-Term Debt	23,750	18,436	20,244	22,902	26,259	20,353
Long-Term Leases	1,596	1,598	1,538	1,621	1,719	1,703
Long-Term Deferred Tax Liabilities	2,216	2,248	2,686	3,070	3,141	5,867
Other Long-Term Liabilities	4,389	1,793	2,267	2,383	2,216	2,005
Total Liabilities	60,083	53,195	58,030	63,973	71,112	62,819
Common Stock	793	825	890	901	913	936
Retained Earnings	46,292	49,649	63,540	70,989	57,157	59,275
Treasury Stock	-40	-41	-92	-48	-53	-80
Comprehensive Income & Other	-3,728	-3,766	-4,996	-4,187	-1,419	-4,657
Total Common Equity	43,317	46,667	59,342	67,655	56,598	55,474
Minority Interest	124	83	81	167	68	77
Shareholders' Equity	43,441	46,750	59,423	67,822	56,666	55,551
Total Liabilities & Equity	103,524	99,945	117,453	131,795	127,778	118,370
Total Debt	32,159	26,439	27,964	31,093	38,049	29,333
Net Cash (Debt)	-18,308	-12,366	-9,238	-2,869	-26,645	-17,989
Net Cash Per Share	-8.92	-5.91	-4.20	-1.27	-11.60	-7.76
Filing Date Shares Outstanding	1,999	2,044	2,120	2,235	2,257	2,265
Total Common Shares Outstanding	1,999	2,044	2,120	2,235	2,257	2,265
Working Capital	3,132	4,091	8,254	15,510	-3,386	1,240
Book Value Per Share	21.67	22.83	28.00	30.27	25.08	24.49
Tangible Book Value	-9,515	1,776	2,818	9,377	-5,510	5,587
Tangible Book Value Per Share	-4.76	0.87	1.33	4.20	-2.44	2.47
Land	-	403	451	492	555	512
Buildings	-	10,147	11,396	11,819	12,377	11,463
Machinery	-	9,630	11,842	13,328	14,038	13,674
Construction In Progress	-	1,213	1,184	1,508	1,248	1,350

Source: S&P Capital IQ. Standard template. Financial Sources.